RGNX
REGENXBIODNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RGNX vs peer average
44/100
RGNX vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
FDMT is the first available peer comparator.
Small-cap gene-therapy peer useful for comparing binary clinical, regulatory, and financing risk; product and indication overlap remain limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RGNX
REGENXBIO
FDMT
4D Molecular Therapeutics
Grade
D
F
Momentum
10
96
Value
41
41
Sentiment
50
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs FDMT
RGNX / FDMT
Grade Position
Below peers
RGNX vs. peer average (D vs. D)
44/100
Momentum
10
FDMTValue
41
RGNXSentiment
50
RGNXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RGNX
FDMT is the first peer returned for this comparison set.